Estimation of glomerular filtration rate using serum cystatin C in overweight and obese subjects

Medical Journal of Malaysia

Volumn 66, Issue 4, 2011, Pages 313-317

  Norli Marwyne, M N ^a   Loo, C Y ^a   Halim, A G ^a   Norella, K ^a   Sulaiman, T ^a   Zaleha, M I ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

Chronic kidney disease; Creatinine; Cystatin C; Estimated glomerular filtration rate; Obese; Overweight

Indexed keywords

CREATININE; CYSTATIN C; PENTETATE TECHNETIUM TC 99M;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; KIDNEY SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; OBESITY; PRACTICE GUIDELINE; PREVALENCE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PROSPECTIVE STUDIES; ROC CURVE;

EID: 83755225427     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. National Kidney Foundation K/DOQI: Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Part 4: Definition and Classification of Stages of Chronic Kidney Disease. Am J Kidney Dis. 2002; 39(2): S1-S200.
2. Must A, Spadano EH, Coakley EH, Field AE, Golditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999; 282: 1523-9.
3. The Asia Pacific perspective: Redefining obesity and its treatment. February 2000. Co-sponsored by the Regional Office for the Western Pacific (WPRO), World Health Organization and the International Obesity Task Force.
4. Gelber RP, Kurth T, Kausz AT, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005; 46: 871-80.
5. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new onset kidney disease in a community based population. JAMA. 2004; 291: 844-50.
6. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end stage renal disease. Ann Intern Med. 2006;144: 21-28.
7. Iseki K, Ikemiya Y, Kinjo K, Inonue T, Iseki C, Takishita S. Body mass index and the risk of development of end stage renal disease in a screened cohort. Kidney Int. 2004; 65:1870-6.
8. Ejerblad E, Fored CM, Lindblad P, Fryzek J, Mc Laughlin JK, Nyren O. Obesity and risk for chronic renal failure. J Am Soc Nephrol. 2006; 17: 1695-702.
9. Hall JE, Henegar JR, Dwyer TM, et al. Is obesity a major cause of chronic kidney disease? Adv Ren Replace Ther. 2004; 11: 41-54.
10. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem. 1992; 38(10): 1933-53.
11. Beddhu S, Samore MH, Roberts MS, Stoddard GJ, Pappas LM, Cheung AK. Creatinine production, nutrition and glomerular filtration rate measurement. J Am Soc Nephrol. 2003; 14: 1000-5.
12. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron.1976;16: 31-41.
13. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol. 2000; 11: 155A.
14. Nor-Hayati Shaharudin, Abdul Halim Abdul Gafor, Soehardy Zainudin, Norella CT Kong, Aini Abdul Aziz, Shamsul-Azhar Shah. Estimating glomerular filtration rate in overweight and obese Malaysian subjects. Int J Nephrol Urol.2011; 3(1): 15-22.
15. Shara NM, Resnick HE, Lu L, et al. Decreased GFR estimated by MDRD or Cockcroft-Gault equation predicts incident CVD: the strong heart study. J Nephrol. 2009; 22(3): 373-80.
16. Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for non invasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000; 36: 29-34.
17. Newman DJ, Thakkar H, Edwards RG, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker changes in GFR than serum creatinine. Kidney Int. 1995; 47: 312-8.
18. Gokkusu CA, Oden TA, Gul H, Yildiz A. Relationship between plasma Cystatin C and creatinine in chronic renal diseases and Tx-transplant patients. Clin Biochem. 2004; 37: 94-7.
19. Muntner P, Winston J, Uribarri J, Mann D, Fox CS. Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med. 2008; 121: 341-8.
20. Retnakaran R, Connelly PW, Harris SB, Zinman B, Hanley AJ. Cystatin C is associated with cardiovascular risk factors and metabolic syndrome in Aboriginal youth. Pediatr Nephrol. 2007; 22: 1007-13.
21. Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004; 65: 1416-21.
22. Fried LF, Lee JS, Shlipak M, et al. Chronic kidney disease and functional limitation in older people: Health, Aging and Body Composition Study. J Am Geriatr Soc. 2006; 54: 750-6.
23. Larsson A, Malm J, Grubb, A et al. Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest. 2004; 64: 25-30.
24. DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med. 1916; 17: 863-71.
25. Eknoyan Garabed Adolphe Quetelet (1796-1874)-the average man and indices of obesity. Nephrol. Dial. Transplant. 23 (1): 47-51.
26. WHO Consultation on Obesity. Obesity: Preventing and Managing the Global Epidemic. WHO Technical report Series 894, Geneva, 2000.
27. Lin J, Knight EL, Hogan ML, Singh AK. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Nephrol. 2003; 14: 2573-80.
28. Taleb S, Cancello R, Clement K, Lacasa D. Cathepsin s promotes human preadipocyte differentiation: Possible involvement of fibronectin degradation. Endocrinology. 2006.147: 4950-9.
29. Naour N, Fellahi S, Renucci JF, et al. Potential contribution of adipose tissue to elevated serum cystatin C in human obesity. 2009; 17(12): 2121-6.
30. Letellier G, Desjarlais F. Analytical interferences of drugs in clinical chemistry II-The interference of three cephalosporins with the determination of serum creatinine concentration by Jaffe reaction. Clin Biochem. 1985; 18: 352-26.
31. Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C serum concentrations underestimate glomerular filtration rate in renal transplant recipients. Clin Chem. 1999; 45: 1866-8.
32. Saracino A, Morrone LF, Suriano V, et al. A simple method for correcting overestimated glomerular filtration rate in obese subjects evaluated by the Cockcroft and Gault formula: a comparison with 51Cr EDTA clearance. Clin Nephrol. 2004; 62: 97-103.
33. Fabbian F, Pala M, Scanelli G, Manzato E, Longhini C, Portaluppi F. Estimation of renal function in patients with eating disorders. Int J Eat Disord. 2010.
34. Josef Coresh; Elizabeth Selvin; Lesley A. Stevens; et al. Prevalence of chronic kidney disease in United States. JAMA. 2007;298(17):2038-2047
35. Abrass CK. Overview: Obesity-what does it have to do with kidney disease. J Am Soc Nephrol. 2004; 15: 2768-72.
36. Bagby SP. Obesity-Initiated Metabolic Syndrome and the Kidney: A recipe for Chronic Kidney Disease? J Am Soc Nephrol. 2004; 15:2775-2791.
37. Zhang R, Liao J, Morse S, et al. Kidney disease and the metabolic syndrome. Am J Med Sc. 2005; 330(6): 319-25.